Accès ouvert
2026
article
OpenAlex
Julia Scarisbrick, Larisa Geskin, Sima Rozati, Erika Morsia et autres
Patients with mycosis fungoides (MF) or Sézary syndrome (SS) may experience visible lesions, severe itch, sleep disturbance, body temperature dysregulation and depression. In this international study, 73 patients completed a symptom diary and questionnaires relating to fatigue and health-related quality of life …
gb
(code pays fourni par la source)
2025
article
OpenAlex
F. Serpenti, Nicole Galli, Francesca Cavallaro, Kordelia Barbullushi et autres
it
(code pays fourni par la source)
2025
article
OpenAlex
Patrizia Bono, Alessandro Parisi, Elena Tagliaferri, Riccardo Ungaro et autres
it
(code pays fourni par la source)
2025
article
OpenAlex
Julia Scarisbrick, Larisa J. Geskin, Sima Rozati, Erika Morsia et autres
Accès ouvert
2025
article
OpenAlex
Cecilia Anna Fidanza, Fabio Serpenti, Francesca Cavallaro, Kordelia Barbullushi et autres
Allogeneic hematopoietic cell transplantation (alloHCT) remains a potential curative option for patients with relapse/refractory (R/R) Hodgkin lymphoma (HL).1,2 The effective bridge to alloHCT with immune checkpoint inhibitors (ICIs) is known to be associated with increased transplant morbidity and mortality.3,4 We have read …
it
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Maria Goldaniga
We hereby describe a case of successful therapy with axicabtagene ciloleucel (axi-cel) chimeric antigen receptor T-cells (CAR-T) in an elderly patient suffering from DLBCL refractory to first-line chemoimmunotherapy, with particular reference to the setting of the diagnostic/therapeutic path and collaboration between the …
it
(code pays fourni par la source)
Accès ouvert
2024
conference-abstract
OpenAlex
Nicolò Rampi, Alessandro Bosi, Michele Merli, Maria Goldaniga et autres
Background: Post-transplant lymphoproliferative disorder (PTLD) is a rare and potentially life-threatening complication of solid organ transplantation (SOT) and allogeneic hematopoietic stem cell transplantation (HSCT), affecting up to 10-20% of recipients. Prognosis is highly variable, and several prognostic factors have been identified. Real-life …
it
(code pays fourni par la source)
Accès ouvert
2024
conference-abstract
OpenAlex
Fabio Serpenti, Cecilia Anna Fidanza, Kordelia Barbullushi, Francesca Cavallaro et autres
Introduction Post-allogeneic hematopoietic cell transplantation (allo-HCT) relapse of acute lymphoblastic leukemia (ALL) is associated with a median overall survival (OS) inferior to 6 months. Limited evidence is available on the use of donor lymphocyte infusion (DLI) in ALL. In the setting of …
it
(code pays fourni par la source)
2024
conference-abstract
OpenAlex
J. Scarisbrick, Arvind Arumainathan, Rebecca G. Cowan, John A. DeSimone et autres
2023
article
OpenAlex
Julia Scarisbrick, Angela Williams, Marco Ardigò, Arvind Arumainathan et autres
2023
article
OpenAlex
Francesco Onida, Francesca Cavallaro, Silvia Alberti Violetti, Maria Goldaniga et autres
2023
article
OpenAlex
Giulio Cassanello, F. Serpenti, Filippo Bagnoli, Giorgia Saporiti et autres
it
(code pays fourni par la source)